Indravadan Gatiwala, MD
Neurology · Lumberton, NCNPI 1144227638
Payments from drug & device makers
Across 717 payments — averaging $33.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$11K
- Livanova USA, Inc.$2K
- Biogen$1K
- UCB, Inc.$794
- Jazz Pharmaceuticals Inc.$765
- Sunovion Pharmaceuticals Inc.$717
- plus $7K from 49 others
What the payments were for
- Consulting fees$6002%
- Speaking & faculty fees$9,70440%
- Travel & lodging$2,2569%
- Food & beverage$11,36847%
- Education$1090%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$10,835
- VNS Therapy$1,724
- TYSABRI$600
How this compares
$24,037 in reported general payments places this provider in the 75th percentile of 566 neurology providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 36 | $818,469 |
| OctagamImmun Globg(Igg)/Malt/Iga Ov50 | 49 | $649,994 |
| GammakedImmune Globul G/Gly/Iga Avg 46 | 34 | $432,110 |
| Gamunex-CImmune Globul G/Gly/Iga Avg 46 | 38 | $344,271 |
| Kesimpta PenOfatumumab | 20 | $213,783 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 17 | $170,603 |
| AptiomEslicarbazepine Acetate | 63 | $104,853 |
| NuplazidPimavanserin Tartrate | 19 | $87,245 |
| VyeptiEptinezumab-Jjmr | 11 | $59,765 |
| Nurtec OdtRimegepant Sulfate | 26 | $41,841 |
| NuedextaDextromethorphan Hbr/Quinidine | 27 | $40,882 |
| GocovriAmantadine Hcl | 21 | $40,417 |
| Aimovig AutoinjectorErenumab-Aooe | 30 | $37,236 |
| RexultiBrexpiprazole | 25 | $36,214 |
| NamzaricMemantine Hcl/Donepezil Hcl | 29 | $21,546 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerOctagam, Nurtec Odt | $653 | $691,83675 claims |
| Kedrion Biopharma, Inc.Gammaked | $18 | $432,11034 claims |
| Grifols USA, LLCGamunex-C | $63 | $344,27138 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid | $137 | $170,60317 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $717 | $104,85363 claims |
| Acadia Pharmaceuticals IncNuplazid | $301 | $87,24519 claims |
| Lundbeck LLCVyepti | $552 | $59,76511 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $91 | $40,88227 claims |
| MDD US Operations, LLCGocovri | $83 | $40,41721 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $59 | $36,21425 claims |
| AbbVieNamzaric | $11,278 | $21,54629 claims |
| UCB, Inc.Briviact | $794 | $15,75711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 566 neurology providers in North Carolina.
Other neurology in Lumberton
- Mohammad BolouriCharlotte$16.6M
- Katherine PetersDurham$11M
- John ScagnelliRaleigh$9.3M
- T RaoCharlotte$4M
- Pramod SethiGreensboro$2.9M
- Robert ArmstrongAsheville$2.7M
- Casey JeffreysRaleigh$2.2M
- Mitchell IsaacWinston Salem$2.2M
- Vern JuelDurham$2M
- Marshall FreemanGreensboro$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.